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Abstract: Lipid deposition inside the arterial wall is a hallmark of plaque 
vulnerability. Based on overtone absorption of C-H bonds, intravascular 
photoacoustic (IVPA) catheter is a promising technology for quantifying 
the amount of lipid and its spatial distribution inside the arterial wall. Thus 
far, the clinical translation of IVPA technology is limited by its slow 
imaging speed due to lack of a high-pulse-energy high-repetition-rate laser 
source for lipid-specific first overtone excitation at 1.7 μm. Here, we 
demonstrate a potassium titanyl phosphate (KTP)-based optical parametric 
oscillator with output pulse energy up to 2 mJ at a wavelength of 1724 nm 
and with a repetition rate of 500 Hz. Using this laser and a ring-shape 
transducer, IVPA imaging at speed of 1 frame per sec was demonstrated. 
Performance of the IVPA imaging system’s resolution, sensitivity, and 
specificity were characterized by carbon fiber and a lipid-mimicking 
phantom. The clinical utility of this technology was further evaluated ex 
vivo in an excised atherosclerotic human femoral artery with comparison to 
histology. 
©2015 Optical Society of America 
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1. Introduction 
The majority of fatal acute coronary syndromes are due to plaque rupture and thrombosis [1–
4]. Pathophysiological assessment of atherosclerotic lesions have demonstrated that lesions 
more prone or “vulnerable” to rupture and thrombosis contain large lipid cores and are 
located in areas of high shear stress within the coronary arterial wall [2,5,6]. Currently, no 
clinically available imaging devices can reliably and accurately diagnose vulnerable plaques 
[7]. Imaging modalities, which include magnetic resonance angiography, computed 
tomography angiography and X-ray angiography are used primarily to image the 
encroachment of plaques on the artery lumen, which is not always predictive of lipid core size 
or plaque vulnerability. Among the current interventional imaging approaches, intravascular 
ultrasound (IVUS) lacks the chemical selectivity to determine the lipid-composition of the 
vessel wall [8], even for the most recently demonstrated multi-frequency IVUS method [9]. 
The so-called “virtual histology” based on IVUS image processing has been challenged [10]. 
Intravascular near infrared spectroscopy can detect lipids in the vessel wall with high 
specificity, but doesn’t provide enough depth to visualize its overall distribution in the artery 
[11,12]. Intravascular optical coherence tomography accurately detects the surface layer of 
arterial wall with micron-scale resolution, but has neither sufficient imaging depth nor 
chemical selectivity to determine plaque composition [13]. These limitations highlight an 
unmet clinical need for a novel intravascular imaging system maintaining both chemical 
selectivity and depth resolution. 
Catheter-based intravascular photoacoustic (IVPA) imaging is considered as a promising 
modality to bridge the aforementioned gap. Combining nanosecond pulsed laser excitation 
with ultrasonic detection, IVPA catheters map chemical compositions in the artery based on 
their optical absorption. Photoacoustic (PA) imaging of lipid-rich plaques has been 
demonstrated under different wavelengths [14–16]. As reported, the 1.2 and 1.7 µm spectral 
bands resonant with the second and first overtone vibrations of the C-H bond and are suitable 
for IVPA imaging of lipid-rich plaques [17–19]. Compared with 1.2 µm excitation, 1.7 µm is 
more favorable for IVPA imaging due to the high absorption coefficient and less optical 
scattering by blood [18,20,21]. A few groups have demonstrated the feasibility of IVPA 
imaging of lipid-laden plaques by excitation at 1.7 µm, even in the presence of blood 
[18,19,22]. More recently, the in vivo feasibility test has been performed in animal models 
[23,24]. However, the in vivo imaging applications of IVPA technology is blocked by the 
slow imaging speed due to the lack of a high-pulse-energy high-repetition-rate laser source 
for high-speed lipid-specific excitation at 1.7 µm. The traditionally used optical parametric 
oscillator (OPO) lasers operate at 10-20 Hz repetition rate. Such a low repetition rate 
translates to a cross-sectional imaging speed of 50 s per frame of 500 A-lines, which is 
marginally useful for clinical applications. Recently, Song and associates demonstrated 
catheter-based high-speed PA imaging of phantoms containing perivascular fat using a 
commercial 1-kHz OPO at the wavelength of 1.7 µm [25]. The low pulse energy (~30 µJ) of 
commercial OPO lasers, however, makes it difficult to generate data from real vascular 
tissues. 
Here, we demonstrate a potassium titanyl phosphate (KTP)-based OPO with a pulse 
energy up to 2 mJ at a wavelength of 1724 nm and with a repetition rate of 500 Hz. Our laser 
outputs stable pulses with pulse duration of 13.2 ns and pulse-to-pulse variation of 6.3%. To 
obtain such high pulse energy and high repetition rate, we adopted two KTP crystals cut with 
a special angle and placed with adverse orientation to effectively minimize the walk-off 
effect. With this laser, we successfully performed human artery imaging ex vivo with an 
imaging speed as high as 1 frame per sec, which is about 50-fold faster than previously 
reported IVPA systems at 1.7 µm excitation [18,19,26]. 
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2. Method and material 
2.1 KTP-based OPO laser 
We designed and constructed the compatible KTP-based OPO with high pulse energy and 
high repetition rate for the demanding need of high-speed IVPA imaging. A schematic 
diagram of the OPO laser was shown in Fig. 1. Two fiber-coupled laser diodes (LDs) with a 
30 W maximum output power at 808 nm were used as the pump source. The pump light was 
coupled into both sides of the laser crystal at the same time by two groups of 2:5 coupling 
lenses. A 0.3%-doped composite Nd:YAG crystal (diameter, 4 mm; length, 40 mm) was used 
as the active medium. Here, the long crystal was chosen to reduce the damage to the pump 
LDs caused by the unabsorbed diode laser; while a composite Nd:YAG crystal with low 
doping was chosen to reduce the thermal lens effect and achieve a high-quality beam for the 
original fundamental laser, which helped to improve the conversion efficiency. This crystal 
had a 5 mm-long un-doped part on both distal ends and had the distal surfaces antireflection 
(AR) coated at both 808 and 1064 nm. A plane-plane resonating cavity was adopted in the 
laser system, which included the Nd:YAG crystal, mirrors M1 and M2, two fold mirrors, and 
an electro-optic (E-O) Q-switch (light green color framed). The flat mirror M1 was high-
reflection (HR) coated at 1064 nm. The output mirror M2 was coated with a transmittance 
equivalent of 60% at 1064 nm. Two fold mirrors were AR coated at 808 nm and HR coated at 
1064 nm. The E-O Q-switch was composed of a polarizer, a quarter-wave plate and a 
potassium dideuterium phosphate (KD*P) Pockels cell. The pump had a pulse duration of 230 
μs, which just closely matches the lifetime of the upper laser level for an Nd:YAG crystal. At 
the cavity output, the 1064 nm beam with pulse energy of 11 mJ was obtained with good 
beam quality and then redirected to the OPO by reflective mirrors M3 and M4 (both HR 
coated at 1064 nm). The OPO (light pink color framed) was composed of flat mirrors M5 and 
M6 and two KTP crystals. M5 was AR coated at 1064 nm and HR coated at the signal 
wavelength. M6 was AR coated at 1064 nm and had 40% partial transmittance at the signal 
wavelength. Both of the mirrors were made of quartz to avoid absorption at the signal laser. 
 
Fig. 1. Schematic of 1.7 μm OPO Laser. M1, M2, M5, M6, flat mirrors; M3, M4, M8, reflective 
mirrors; M7, dichroic mirror; KD*P, potassium dideuterium phosphate Pockels cell; KTP, 
potassium titanyl phosphate. The inset shows the pictures of the actual laser system. 
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Here, the two KTP crystals with a size of 7 × 7 × 20 mm3 were cut in a special way (θ, 
63.5°; Φ, 0°) to realize type II phase matching. It effectively reduced the walk-off effect by 
placing two KTP crystals with adverse orientations, while the effective nonlinear coefficient 
was still acceptable [27,28]. In order to reduce loss, both sides of the KTP crystals were AR 
coated at the pump, signal, and idler light. In the laser system, the length of the OPO cavity 
was designed to be as short as 44 mm, since a short length leads to a low conversion threshold 
power density. To dissipate heat effectively, the laser rods and KTP crystals were wrapped 
with indium foil and tightly mounted in water-cooled heat sinks. The temperature of the 
cooling water was kept at around 295 K. After the OPO, the pump beam was separated by the 
dichroic mirror M7 and blocked by a dump; while the signal beam was separated by M7 and 
then redirected to be the final output by the reflective mirror M8. It is important to note that 
all these optical components for the OPO were installed in a compatible aluminum alloy box 
with a size of 36 × 27 × 10 cm3 shown by the inset pictures of Fig. 1. The compactness of the 
laser will make the entire IVPA imaging system much easier for clinical translation in an 
operating room. 
 
Fig. 2. Performance of the KTP-based OPO. (a) Repetition rate; (b) laser emission spectrum; 
(c) output power at different current; (d) pulse duration at different output power; (e) pulse 
duration at output power of 0.726 W; (f) pulse-to-pulse variation. 
We characterized the performance of the KTP-based OPO. Beam quality factor is less 
than 1.3. The pulse repetition rate of the OPO is 500 Hz, as the time interval between every 
two neighboring pulses is 2 ms in Fig. 2(a). The output spectrum was measured by a NIR 
spectrometer (LF-1250, Spectral Evolution, MA). The peak position in the spectrum is 
centered at 1724 nm, which matches the first overtone vibrational band of C-H bond (Fig. 
2(b)). The output power increases with the control current with a maximum power of 1 W (2 
mJ for pulse energy) measured at 8.5 A (Fig. 2(c)). As shown in Fig. 2(d), the pulse duration 
is slightly increased with the output power ranging from 10.7 to 13.7 ns by measuring the 
FWHM of a single laser pulse. The pulse width with the output power of 0.726 W is 13.2 ns, 
at which we performed all of the experiments (Fig. 2(e)). Since PA imaging does not have a 
critical requirement on the pulse width in this range, the OPO can be used for IVPA imaging 
with a different power in this tunable range. The average pulse energy is characterized to be 
1.452 mJ with 0.726 W output power. The pulse energy coupled to the catheter head was kept 
at 0.4 mJ. Thus, the energy density at the surface of the catheter was calculated to be 0.1 
J/cm2, which is below the 1 J/cm2 ANSI safety standard for skin at this wavelength [29]. The 
pulse-to-pulse variation is 6.27% (Fig. 2(f)), which ensures the same amount of photon 
delivery for each A-line at different angles. 
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2.2 High-speed IVPA imaging system 
 
Fig. 3. IVPA/IVUS imaging system. MMF, multimode fiber; L, lens. 
The entire high-speed IVPA imaging system was constructed by integrating the KTP-based 
OPO laser, the IVPA catheter, a scanning system, and data acquisition units (Fig. 3(a)). The 
OPO output was focused by a lens with a focal length of 75 mm into a 200 μm-core 
multimode fiber (FG200LCC, Thorlabs, NJ) mounted on a 3D adjustable stage. After the 2 m 
long fiber, the beam was then coupled into the IVPA catheter by two fixed-focus collimators 
mounted on the scanning system. We designed a co-registered IVPA/IVUS dual-modality 
imaging catheter (inset of Fig. 3(a)). The IVPA catheter was composed of a miniaturized ring-
shape ultrasound transducer (center frequency, 35 MHz; band width, 65%; focal length, 3 
mm), an end-polished 400 μm-core multimode fiber (BFL48-400, Thorlabs, NJ), a 45-degree 
rod mirror with a diameter of 2 mm (Edmund Optics Inc., NJ), a homemade metallic housing 
and a 55 cm long torque coil. For ultrasound transducer, single crystal Pb(Mg1/3Nb2/3)O3-
PbTiO3 was adopted as the function piezoelectric material, which provides superior 
electromechanical coupling coefficient. The transducer/fiber and rod mirror were fixed in a 
metal housing with an open window for both light and sound delivery. Based on same design 
as used in the previous work [21], both the excitation light and the ultrasound transmission 
were reflected 90 degrees by the mirror, which maximized the optical-acoustic overlapping 
area and thus provided the largest sensitivity. The trigger of the laser was used to synchronize 
the data acquisition for both IVPA and IVUS imaging. A delay generator (37000-424, 
Datapulse Inc.) was used to set a 20 μs delay between the laser pulse and the initial ultrasound 
(US) pulse (the voltage of the transmitted pulse, 180 V) generated by an ultrasound 
pulser/receiver (5073PR Olympus, Inc). Both the generated PA and US signals were detected 
by the ring-shape transducer and then sent to the ultrasound pulser/receiver with a total 
amplification of 39 dB. These signals were digitized and transferred by a data acquisition card 
with 16 bits digitization and 180 MS/s sampling rate (ATS9462 PCI express digitizer, 
AlazerTech, Canada) installed in a personal computer (PC). The data acquisition software 
was developed to control, save, and process the recorded data in LabVIEW. The data analysis 
was then performed off-line by Matlab. In the Matlab script, each A-line was band-pass 
filtered (bandwidth: 9.5-50 MHz), Hilbert transformed for the signal envelop and subtracted 
by an averaged background. The final polar image (cross-sectional image) was constructed by 
500 A-lines with a rotation speed of 1 frame per second. The dynamic range of each polar 
image was log compressed and then normalized. None of the images in the experiment was 
averaged. The rotation of the catheter was driven by a scanning system. We designed the 
scanning system by integrating a homebuilt optical rotary joint and a linear stage with an 
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electrical slip ring (LPC-12T, JINPAT Electronics). The optical rotary joint delivered the 
laser light through free-space coupling by the collimators (concentrically aligned with a 
bearing) and rotated the catheter for the cross-sectional scanning. A linear stage was used for 
linear pullback to ultimately acquire three-dimensional imaging. The electrical slip ring was 
used to transmit the recorded signal from the transducer wire to the ultrasound 
pulser/receiver. Both the optical rotary joint and the linear stage were controlled by the PC. 
3. Results 
3.1 Performance test of high-speed IVPA imaging system by phantoms 
 
Fig. 4. IVPA imaging of 30 μm carbon fiber phantom. (a) IVPA image with schematic of 
carbon fiber phantom. Black dot indicates 30 μm carbon fiber. (b) IVUS image. (c) The axial 
and lateral resolutions of IVPA imaging at axial position of 3 mm. (d) The spatial resolutions 
of IVPA imaging as a function of the axial positions. 
To characterize the spatial resolution of the high-speed IVPA imaging system, a carbon fiber 
with a diameter of 30 μm was imaged. As shown in the inset of Fig. 4(a), the carbon fiber was 
placed at the depth of 3 mm in D2O environment. Both PA and US signals were collected and 
reconstructed as IVPA (Fig. 4(a)) and IVUS (Fig. 4(b)) images through the high-speed IVPA 
imaging system. The dynamic ranges for displayed IVPA and IVUS images are 60 dB and 90 
dB, respectively. The co-registration of IVPA and IVUS imaging was clearly reflected. In 
Fig. 4(c), according to the IVPA image, the experimental data of the imaged carbon fiber was 
plotted along its axial and lateral directions, respectively. The dotted lines were then fitted 
with Gaussian functions to estimate the axial and lateral resolutions of IVPA imaging. Based 
on the FWHMs of the fitted functions, the axial resolution is estimated to be 102 μm, while 
the lateral resolution is 260 μm. The axial resolution of IVPA is quite close to that of IVUS, 
since it primarily depends on the transducer bandwidth. In Fig. 4(d), the spatial resolutions of 
IVPA imaging were measured and plotted as a function the axial positions. Both axial and 
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lateral resolutions are maintained at the same levels, which shows the advantage of ring-shape 
transducer-based IVPA catheter. 
To characterize the sensitivity and specificity, we made a lipid-mimicking phantom with 
butter for bond-selective IVPA imaging. The phantom structure is depicted in Fig. 5(a). 2.5% 
agarose-D2O gel acts as the tissue environment. One big hole, for IVPA catheter to be 
inserted in, and three small holes, two filled with butter while one left blank, were reserved in 
the agarose gel. The whole phantom and IVPA catheter were immersed in D2O medium for 
IVPA imaging to avoid water absorption at 1.7 μm. Using the high-speed IVPA imaging 
system, the B-scan IVPA, IVUS and merged IVPA/IVUS images of the phantom were 
obtained and shown in Fig. 5(b), Fig. 5(c) and Fig. 5(d) respectively. In the IVPA image with 
dynamic range of 39 dB, the two holes with butter exhibit strong PA signal while the blank 
hole shows no evident signal. In the IVUS image with dynamic range of 28 dB, all three holes 
provide contrast due to the boundaries of the holes and the butter. The relative positions of the 
holes in the merged image further confirm the co-registration of IVPA and IVUS imaging. 
The results above successfully demonstrated the specificity for high-speed IVPA imaging and 
also the good sensitivity for lipid detection. 
 
Fig. 5. IVPA imaging of lipid-mimicking phantom. (a) Schematic of phantom structure. (b) 
IVPA image. (c) IVUS image. (d) Merged IVPA/IVUS image. 
3.2 Ex vivo high-speed IVPA imaging of human artery with histological validation 
To further validate the high-speed IVPA imaging system, an ex vivo study of an excised 
atherosclerotic human femoral artery was performed. A small section of artery with 
atherosclerotic plaque verified by a microscope was fixed in 2.5% agarose-H2O gel and 
immersed in water for imaging purpose. The IVPA catheter was then inserted into the lumen 
of the artery and rotated at a speed of 1 round per second. 500 A-lines were acquired during a 
cycle to form a cross-sectional image. The IVPA (Fig. 6(a)), IVUS (Fig. 6(b)), and merged 
(Fig. 6(c)) images of the atherosclerotic artery clearly show the complementary information 
#250606 Received 21 Sep 2015; revised 18 Oct 2015; accepted 19 Oct 2015; published 23 Oct 2015 
(C) 2015 OSA 1 Nov 2015 | Vol. 6, No. 11 | DOI:10.1364/BOE.6.004557 | BIOMEDICAL OPTICS EXPRESS 4564 
of the artery wall. Notably, the lipid deposition in the arterial wall indicated by white arrows 
at 2 and 3 o'clock directions, which is not seen in the IVUS image (dynamic range of 70 dB), 
shows high contrast in the IVPA image with dynamic range of 54 dB. The lipid deposition in 
2 and 3 o'clock directions, although spatially stretched and distorted a little bit by the inserting 
catheter indicated by some of the calcium lesion torn, was further confirmed by the gold 
standard histology of the same cross-section of the artery (Fig. 6(d)). In the histology, the 
lipid shows up with red color and areas of calcification are black when stained with Oil Red 
O. The lipid deposition in 7 o'clock direction was not successfully picked up by IVPA 
imaging. There are two possible reasons, either caused by catheter induced spatial distortion 
or by the histology process, where exact the same cross-section was not sliced. During the 
experiment, the energy density at the catheter head was maintained at 0.1 J/cm2, which is 
below the ANSI safety standard for a nanosecond laser at this wavelength. The imaging and 
histology results further confirmed the capability of the high-speed IVPA imaging system for 
lipid detection accurately and specifically. 
 
Fig. 6. High-speed IVPA/IVUS imaging of an excised atherosclerotic human femoral artery. 
(a) IVPA image. (b) IVUS image. (c) Merged IVPA/IVUS image. (d) Cross-sectional view of 
the artery histologically assessed for lipids with Oil-Red-O staining. The red indicates the lipid 
deposition in the artery and the black indicates areas of calcification. 
4. Discussion and conclusion 
In this study, we have developed a compactible KTP-based OPO with an 2 mJ output at the 
wavelength of 1724 nm and repetition rate of 500 Hz and demonstrated its use for high-speed 
IVPA imaging of lipid deposition inside an intact human artery wall. The performance of the 
IVPA imaging system’s resolution, sensitivity and specificity were successfully characterized 
by a 30 μm carbon fiber and a lipid-mimicking phantom through a ring-shape transducer-
based IVPA catheter. The axial and lateral resolutions were measured to be 102 μm and 260 
μm, respectively. Although the catheter we used has a relative large diameter, the constant 
spatial resolutions along the axial positions and the large optical-acoustic overlapping area 
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make this design advantageous when compared with front-back and dual-element transducer 
designs [25,26]. For clinical applications, our catheter size should be further reduced to ~1 
mm in diameter. The size of our IVPA catheter is mainly determined by the size of ring-shape 
transducer. The current size of ring-shape transducer (2.5 mm) is limited by the traditional 
fabrication method of mechanical turning and drilling due to the multi-layer structure of 
transducer as well as the small stiffness of piezoelectric material. Currently, our group is 
working toward to reducing the transducer size down to 1 mm in diameter by using the two 
available advanced micro-machining techniques: laser cutting and inductively coupled plasma 
(ICP)-enhanced deep reactive ion etching (DRIE). Nd: YAD solid-state laser cutting system 
is able to precisely drill and cut the ceramic substrate of ultrasonic transducer with a narrow 
kerf less than 10 microns and up to 1 mm thickness. Moreover, the ICP-DRIE method 
commonly used for composite material fabrication can also be easily adapted to fulfill the 
requirements of transducer minimization. The improvement on spatial resolutions based on 
IVPA catheter designs also increases the detection accuracy of lipid distribution, thus 
provides more accurate diagnosis of plaque vulnerability. 
Another improvement to be addressed is the laser source with even higher repetition rate. 
Currently, the IVPA imaging speed is primarily driven by the availability of high repetition 
rate laser source with wavelengths that generate relative contrasts. In order to make IVPA 
imaging competitive for clinical applications, the imaging speed has to be increased to ~30 
frames/sec, comparable with the typical imaging speed of clinical IVUS. The least number of 
A-lines forming a cross-sectional IVPA image is determined by the lateral resolution. Based 







 with lateral resolution of ~250 μm and viewing depth of 5 mm. 
Thus, the laser repetition rate needs to be at least 3750 Hz. If the number of A-lines is 
increased to be the same with clinical IVUS (256 A-lines typically), then the repetition rate 
needs to be ~7500 Hz. If the lateral resolution goes to the optical resolution, then the 
repetition rate needs to be much higher. Therefore, we need further improve our laser with 
high repetition rate of the order of 10 kHz. It still is possible by using a KTP-based OPO to 
generate the high-energy pulsed laser with ~10 kHz repetition rate at 1.7 μm for clinical 
IVPA imaging and we are now working toward to engineering such laser. Moreover, the 
compactness of the laser facilitates clinical translation of the IVPA imaging system. 
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